-
1
-
-
65349160910
-
ABN Guidelines for 2007 (Updated from 2001)
-
Association of British Neurologists, London: Association of British Neurologists
-
Association of British Neurologists. ABN Guidelines for 2007 (Updated from 2001). Treatment of multiple sclerosis with β-interferon and glatiramer acetate. London: Association of British Neurologists, 2007
-
(2007)
Treatment of multiple sclerosis with β-interferon and glatiramer acetate
-
-
-
3
-
-
54149084585
-
Multiple sclerosis
-
Compston A, Coles A. Multiple sclerosis. Lancet 2008;372:1502-17
-
(2008)
Lancet
, vol.372
, pp. 1502-1517
-
-
Compston, A.1
Coles, A.2
-
4
-
-
54049140996
-
Neuromyelitis optica: Diagnosis, pathogenesis, and treatment
-
Cree B. Neuromyelitis optica: diagnosis, pathogenesis, and treatment. Curr Neurol Neurosci Rep 2008;8:427-33.
-
(2008)
Curr Neurol Neurosci Rep
, vol.8
, pp. 427-433
-
-
Cree, B.1
-
5
-
-
44949141642
-
Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis
-
CD005278
-
Clerico M, Faggiano F, Palace J, et al. Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis. Cochrane Database Syst Rev 008;(2):CD005278
-
Cochrane Database Syst Rev 008
-
-
Clerico, M.1
Faggiano, F.2
Palace, J.3
-
6
-
-
54049087015
-
Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
-
Goodin DS, Cohen BA, O'Connor P, et al, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008;71:766-73.
-
(2008)
Neurology
, vol.71
, pp. 766-773
-
-
Goodin, D.S.1
Cohen, B.A.2
O'Connor, P.3
-
7
-
-
34547661898
-
Neutralising antibodies to interferon beta in multiple sclerosis: Expert panel report
-
Hartung HP, Polman C, Bertolotto A, et al. Neutralising antibodies to interferon beta in multiple sclerosis: expert panel report. J Neurol 2007;254:827-37.
-
(2007)
J Neurol
, vol.254
, pp. 827-837
-
-
Hartung, H.P.1
Polman, C.2
Bertolotto, A.3
-
8
-
-
5444248509
-
Multiple sclerosis. Management of multiple sclerosis in primary and secondary care
-
NICE Guidelines, 8 November, Developed by the National Collaborating Centre for Chronic Conditions
-
NICE Guidelines. Multiple sclerosis. Management of multiple sclerosis in primary and secondary care. Clinical Guideline 8 November 2003. Developed by the National Collaborating Centre for Chronic Conditions.
-
(2003)
Clinical Guideline
-
-
-
9
-
-
28544436950
-
Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald Criteria''
-
Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the ''McDonald Criteria''. Ann Neurol 2005;58:840-6.
-
(2005)
Ann Neurol
, vol.58
, pp. 840-846
-
-
Polman, C.H.1
Reingold, S.C.2
Edan, G.3
-
10
-
-
39449121111
-
Acute disseminated encephalomyelitis: Current understanding and controversies
-
Young NP, Weinshenker BG, Lucchinetti CF. Acute disseminated encephalomyelitis: current understanding and controversies. Semin Neurol 2008;28:84-94.
-
(2008)
Semin Neurol
, vol.28
, pp. 84-94
-
-
Young, N.P.1
Weinshenker, B.G.2
Lucchinetti, C.F.3
|